TPRG1
Chr 3tumor protein p63 regulated 1
Also known as: FAM79B
LOEUF 1.72
Clinical Summary— TPRG1
⚡
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available
Population Genetics & Constraint
gnomAD v4 — loss-of-function & missense intolerance
Tolerant — LoF & missense variants common in population
LoF Constraint?
1.72LOEUF
pLI 0.000
Z-score -0.42
OE 1.13 (0.74–1.72)
Highly tolerant — LoF variants common in population
Missense Constraint?
-0.48Z-score
OE missense 1.11 (0.98–1.26)
169 obs / 152.3 exp
Tolerant to missense variation
Observed / Expected Ratios?
LoF OE?1.13 (0.74–1.72)
0≤0.351.4
Missense OE?1.11 (0.98–1.26)
0≤0.61.4
Synonymous OE?1.05
0≤1.21.6
LoF obs/exp: 14 / 12.4Missense obs/exp: 169 / 152.3Syn Z: -0.30
ClinVar Variant Classifications
0 submitted variants in ClinVar
Protein Context — Lollipop Plot
TPRG1 · protein map & ClinVar variants
Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.
External Resources
Links to major genomics databases and tools
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
External Resources
Links to major genomics databases and tools